VLX
(2S)-2-[(4R)-2-oxidanylidene-4-propyl-pyrrolidin-1-yl]butanamide
Find entries where: VLX
is present as a standalone ligand in 2 entries
Chemical Component Summary | |
---|---|
Name | (2S)-2-[(4R)-2-oxidanylidene-4-propyl-pyrrolidin-1-yl]butanamide |
Identifiers | (2~{S})-2-[(4~{R})-2-oxidanylidene-4-propyl-pyrrolidin-1-yl]butanamide |
Formula | C11 H20 N2 O2 |
Molecular Weight | 212.289 |
Type | NON-POLYMER |
Isomeric SMILES | CCC[C@@H]1CC(=O)N(C1)[C@@H](CC)C(=O)N |
InChI | InChI=1S/C11H20N2O2/c1-3-5-8-6-10(14)13(7-8)9(4-2)11(12)15/h8-9H,3-7H2,1-2H3,(H2,12,15)/t8-,9+/m1/s1 |
InChIKey | MSYKRHVOOPPJKU-BDAKNGLRSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 35 |
Chiral Atom Count | 2 |
Bond Count | 35 |
Aromatic Bond Count | 0 |
Drug Info: DrugBank
DrugBank ID | DB05541 |
---|---|
Name | Brivaracetam |
Groups |
|
Description | Brivaracetam is a racetam derivative of levetiracetam used in the treatment of partial-onset seizures. Brivaracetam binds SV2A with 20 times higher affinity than levetiracetam [A19184]. It is available under the brand name Briviact made by UCB. Briviact received FDA approval on February 19, 2016 [L760]. |
Synonyms | Brivaracetam |
Brand Names |
|
Indication | Used as adjunctive therapy for partial-onset seizures in patients 16 years of age or older. |
Categories |
|
ATC-Code | N03AX23 |
CAS number | 357336-20-0 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Synaptic vesicle glycoprotein 2A | MEEGFRDRAAFIRGAKDIAKEVKKHAAKKVVKGLDRVQDEYSRRSYSRFE... | unknown | unknown |
Sodium channel protein | MEQTVLVPPGPDSFNFFTRESLAAIERRIAEEKAKNPKPDKKDDDENGPK... | unknown | inhibitor |
Cytochrome P450 3A4 | MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI... | unknown | substrate |
Cytochrome P450 2C19 | MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV... | unknown | substrate |
Cytochrome P450 2B6 | MELSVLLFLALLTGLLLLLVQRHPNTHDRLPPGPRPLPLLGNLLQMDRRG... | unknown | substrate |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL607400 |
PubChem | 9837243 |
ChEMBL | CHEMBL607400 |
ChEBI | CHEBI:133013 |
CCDC/CSD | NASROP01, NASROP, ZIKFOR |